CytoDyn Inc (OTCPK:CYDY)
$ 0.1246 -0.0024 (-1.89%) Market Cap: 151.99 Mil Enterprise Value: 159.16 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Cytodyn Inc Wall Street Reporter Transcript

May 01, 2020 / NTS GMT
Release Date Price: $3.2 (-8.71%)
Jack Marks
Wall Street Reporter - Moderator

Okay. Good afternoon, everybody, and welcome to Wall Street Reporter NEXT SUPER STOCK Livestream for today, May 1, 2020. We have another special presentation today from CytoDyn. The [stock], many of you have been following since they first presented at our live stream back in August.

The stock is up tremendously making new highs every day this week. And today we're going to find out what's going to be next for the company. And if this is just the start of even bigger things to come. So we're going to have Dr. Bruce Patterson joining. We have, of course, Dr. Nader Pourhassan, the CEO. (Conference Instructions)

So with that said, Nader, I will turn it over to you.

Nader Pourhassan
CytoDyn Inc. - President & CEO

Thank you, Jack. And thanks, everyone, for being on the call. In today's presentation, as always, we are going to be making a lot of forward-looking statements and information. I'm not going to spend a lot of time on the background of the company, I think everybody knows that. There's a very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot